Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
abatacept golimumab

increases risk of generalisedinfection(possiblylife-threatening)

Severe Theoretical
abatacept monoclonalantibodies

increases risk of generalisedinfection(possiblylife-threatening)

Severe Theoretical
aceinhibitors icatibantandicatibantispredictedtodecreasetheefficacyof

decreases efficacy

Severe Theoretical
acetazolamide methenamine

decreases efficacy

Severe Theoretical
acitretin methotrexate

increases concentration

Severe Anecdotal
alemtuzumab fingolimod

increases risk of generalisedinfection(possiblylife-threatening)

Severe Theoretical
alemtuzumab ozanimod

increases risk of generalisedinfection(possiblylife-threatening)

Severe Theoretical
alemtuzumab siponimod

increases risk of generalisedinfection(possiblylife-threatening)

Severe Theoretical
aluminiumhydroxide deferasirox

decreases exposure

Severe Theoretical
amfetamines apraclonidine

decreases effects

Severe Theoretical
amfetamines moclobemide

increases risk of ahypertensivecrisis

Severe Theoretical
aminoglycosides agalsidasealfa

decreases effects

Severe Theoretical
aminoglycosides agalsidasebeta

decreases effects

Severe Theoretical
aminophylline phosphodiesterasetype-

increases exposure

Severe Theoretical
aminophylline roflumilast

increases exposure

Severe Theoretical
amiodarone agalsidasealfa

decreases effects

Severe Theoretical
amiodarone agalsidasebeta

decreases effects

Severe Theoretical
amiodarone calciumchannelblockers

increases risk of cardiodepression

Severe Theoretical
amiodarone diltiazem

increases risk of cardiodepression

Severe Theoretical
amiodarone thyroidhormones

increases risk of thyroiddysfunction

Severe Study
amiodarone verapamil

increases risk of cardiodepression

Severe Theoretical
amitriptyline metyrapone

decreases effects

Severe Theoretical
anakinra etanercept

increases risk of generalisedinfection(possiblylife-threatening)

Severe Theoretical
anakinra golimumab

increases risk of generalisedinfection(possiblylife-threatening)

Severe Theoretical
anakinra monoclonalantibodies

increases risk of generalisedinfection(possiblylife-threatening)

Severe Theoretical
anthracyclines monoclonalantibodies

increases risk of cardiotoxicity

Severe Theoretical
anthracyclines trastuzumab

increases risk of cardiotoxicity

Severe Theoretical
anthracyclines trastuzumabemtansine

increases risk of cardiotoxicity

Severe Theoretical
antiepileptics(carbamazepine,fosphenytoin,oxcarbazepine, phenobarbital,phenytoin,primidone imatinib

decreases exposure

Severe Study
antiepileptics(carbamazepine,fosphenytoin,oxcarbazepine, phenobarbital,phenytoin,primidone tenofoviralafenamide

decreases exposure

Severe Theoretical
antiepileptics(carbamazepine,fosphenytoin,phenobarbital, phenytoin,primidone elexacaftor

decreases exposure

Severe Theoretical
antiepileptics(carbamazepine,fosphenytoin,phenobarbital, phenytoin,primidone remdesivir

decreases exposure

Severe Theoretical
antiepileptics(carbamazepine,fosphenytoin,phenobarbital, phenytoin,primidone tepotinib

decreases exposure

Severe Theoretical
antiepileptics(fosphenytoin,phenobarbital,phenytoin, primidone metyrapone

decreases effects

Severe Study
antifungals,azoles acalabrutinib

increases exposure

Severe Study
antifungals,azoles antipsychotics,secondgeneration

increases exposure

Severe Study
antifungals,azoles bedaquiline

increases exposure

Severe Theoretical
antifungals,azoles cariprazine

increases exposure

Severe Study
antifungals,azoles entrectinib

increases exposure

Severe Theoretical
antifungals,azoles lomitapide

increases exposure

Severe Theoretical
antifungals,azoles mobocertinib

increases exposure

Severe Study
antifungals,azoles neratinib

increases exposure

Severe Study
antifungals,azoles olaparib

increases exposure

Severe Theoretical
antifungals,azoles pimozide

increases exposure

Severe Theoretical
antifungals,azoles quetiapine

increases exposure

Severe Study
antifungals,azoles rimegepant

increases exposure

Severe Study
antifungals,azoles tepotinib

increases exposure

Severe Theoretical
antifungals,azoles zanubrutinib

increases exposure

Severe Theoretical
antifungals,azoles(itraconazole,ketoconazole,posaconazole, r voriconazole crizotinib

increases exposure

Severe Study
antifungals,azoles(itraconazole,ketoconazole,posaconazole, voriconazole crizotinib

increases exposure

Severe Study
6278 interactions
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.